|
|
Other links at Articles > Business of Medicine |
| 2. |
Eli Lilly to Pay $62 Million in Zyprexa Settlement
|
|
|
Eli Lilly and Co has agreed to pay $62 million to settle claims that it improperly marketed its top-selling Zyprexa schizophrenia drug to patients who were not approved users, the company said on Tuesday. Reuters Health Information
|
|
|